BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 11356942)

  • 1. Adaptive gastric cytoprotection is mediated by prostaglandin EP1 receptors: a study using rats and knockout mice.
    Takeuchi K; Araki H; Umeda M; Komoike Y; Suzuki K
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1160-5. PubMed ID: 11356942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facilitation by endogenous prostaglandins of capsaicin-induced gastric protection in rodents through EP2 and IP receptors.
    Takeuchi K; Kato S; Takeeda M; Ogawa Y; Nakashima M; Matsumoto M
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1055-62. PubMed ID: 12604682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E receptor subtypes involved in stimulation of gastroduodenal bicarbonate secretion in rats and mice.
    Takeuchi K; Ukawa H; Furukawa O; Kawauchi S; Araki H; Sugimoto Y; Ishikawa A; Ushikubi F; Narumiya S
    J Physiol Pharmacol; 1999 Jun; 50(2):155-67. PubMed ID: 10424714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric cytoprotection by prostaglandin E₂ and prostacyclin: relationship to EP1 and IP receptors.
    Takeuchi K
    J Physiol Pharmacol; 2014 Feb; 65(1):3-14. PubMed ID: 24622825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of cyclooxygenase-1, prostaglandin E2 and EP1 receptors in acid-induced HCO3- secretion in stomach.
    Takeuchi K; Aihara E; Sasaki Y; Nomura Y; Ise F
    J Physiol Pharmacol; 2006 Dec; 57(4):661-76. PubMed ID: 17229989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The roles of prostaglandin E receptor subtypes in the cytoprotective action of prostaglandin E2 in rat stomach.
    Araki H; Ukawa H; Sugawa Y; Yagi K; Suzuki K; Takeuchi K
    Aliment Pharmacol Ther; 2000 Apr; 14 Suppl 1():116-24. PubMed ID: 10807413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective cyclo-oxygenase-2 inhibitors and their influence on the protective effect of a mild irritant in the rat stomach.
    Gretzer B; Ehrlich K; Maricic N; Lambrecht N; Respondek M; Peskar BM
    Br J Pharmacol; 1998 Mar; 123(5):927-35. PubMed ID: 9535022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric ulcerogenic responses following barrier disruption in knockout mice lacking prostaglandin EP1 receptors.
    Takeuchi K; Ogawa Y; Kagawa S; Ukawa H
    Aliment Pharmacol Ther; 2002 Apr; 16 Suppl 2():74-82. PubMed ID: 11966527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of cyclooxygenase-2 and prostacyclin/IP receptors in mucosal defense against ischemia/reperfusion injury in mouse stomach.
    Kotani T; Kobata A; Nakamura E; Amagase K; Takeuchi K
    J Pharmacol Exp Ther; 2006 Feb; 316(2):547-55. PubMed ID: 16236816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biphasic effect of prostaglandin E2 in a rat model of esophagitis mediated by EP1 receptors: relation to pepsin secretion.
    Yamato M; Nagahama K; Kotani T; Kato S; Takeuchi K
    Digestion; 2005; 72(2-3):109-18. PubMed ID: 16172547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclo-oxygenase isozymes in mucosal ulcergenic and functional responses following barrier disruption in rat stomachs.
    Hirata T; Ukawa H; Yamakuni H; Kato S; Takeuchi K
    Br J Pharmacol; 1997 Oct; 122(3):447-54. PubMed ID: 9351500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2/prostaglandin E2 accelerates the healing of gastric ulcers via EP4 receptors.
    Hatazawa R; Tanaka A; Tanigami M; Amagase K; Kato S; Ashida Y; Takeuchi K
    Am J Physiol Gastrointest Liver Physiol; 2007 Oct; 293(4):G788-97. PubMed ID: 17673547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses.
    Takeuchi K; Suzuki K; Yamamoto H; Araki H; Mizoguchi H; Ukawa H
    J Physiol Pharmacol; 1998 Dec; 49(4):501-13. PubMed ID: 10069692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of endogenous prostaglandins and cyclooxygenase izoenzymes in mucosal defense of inflamed rat stomach.
    Takeeda M; Hayashi Y; Yamato M; Murakami M; Takeuchi K
    J Physiol Pharmacol; 2004 Mar; 55(1 Pt 2):193-205. PubMed ID: 15082878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of the pineal gland, endogenous prostaglandins and sensory nerves in the gastroprotective actions of central and peripheral melatonin against stress-induced damage.
    Brzozowski T; Konturek PC; Zwirska-Korczala K; Konturek SJ; Brzozowska I; Drozdowicz D; Sliwowski Z; Pawlik M; Pawlik WW; Hahn EG
    J Pineal Res; 2005 Nov; 39(4):375-85. PubMed ID: 16207293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms underlying capsaicin-stimulated secretion in the stomach: comparison with mucosal acidification.
    Aihara E; Hayashi M; Sasaki Y; Kobata A; Takeuchi K
    J Pharmacol Exp Ther; 2005 Oct; 315(1):423-32. PubMed ID: 15985616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin EP receptors and their roles in mucosal protection and ulcer healing in the gastrointestinal tract.
    Takeuchi K
    Adv Clin Chem; 2010; 51():121-44. PubMed ID: 20857620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of prostaglandin E receptor EP3 subtype and prostacyclin IP receptor in decreased acid response in damaged stomach.
    Nishio H; Terashima S; Nakashima M; Aihara E; Takeuchi K
    J Physiol Pharmacol; 2007 Sep; 58(3):407-21. PubMed ID: 17928639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inducible types of cyclooxygenase and nitric oxide synthase in adaptive cytoprotection in rat stomachs.
    Yamamoto H; Tanaka A; Kunikata T; Hirata T; Kato S; Takeuchi K
    J Physiol Paris; 1999 Nov; 93(5):405-12. PubMed ID: 10674917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of EP receptor subtypes responsible for prostaglandin E2-induced pain responses by use of EP1 and EP3 receptor knockout mice.
    Minami T; Nakano H; Kobayashi T; Sugimoto Y; Ushikubi F; Ichikawa A; Narumiya S; Ito S
    Br J Pharmacol; 2001 Jun; 133(3):438-44. PubMed ID: 11375261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.